Summary Alteration in MHC class I expression may be used by cancer cells to avoid immune destruction. Much experimental evidence supports this idea, although survival studies are very scarce. To investigate whether the presence or absence of HLA-A, -B and -C antigens in laryngeal carcinoma influences survival, a series of 60 primary laryngeal tumours treated surgically and normal tissues were evaluated in frozen sections for the expression of MHC class I antigens and tumour-infiltrating leucocytes (CD3, CD4, CD8, CD1Ib, CD1, CD20 and CDI6), using monoclonal antibodies and the APAAP technique. Long-term follow-up from the patients is available, ranging from 6 to 10 years. Thirteen tumours presented total HLA-ABC loss, five selective losses of HLA-A antigens and one absence of HLA-B antigens. Total losses were statistically associated with several clinical and pathological parameters, but there were no differences regarding tumour-infiltrating leucocytes. After conducting a prospective study, only T and N staging and scoring according to Glanz's malignancy classification were found to be independently related to patients' outcome. From our data, we conclude that neither complete loss of HLA class I antigens nor tumour-infiltrating leucocytes appear to influence survival in squamous cell carcinoma of the larynx.
MHC class I antigens are membrane glycoproteins involved in effective killing by cytotoxic T cells, which require HLA class I compatibility between T cells and target cells (Thorsby, 1982; Festenstein and Garrido, 1986) . Alterations in HLA-ABC expression may be one method used by cancer cells to avoid immune destruction (Garrido, 1987) . Decreased HLA expression has been discovered in several human tumours, including breast, lung, skin, colorectal, gastric and laryngeal carcinomas (L6pez-Nevot et al., 1986 (L6pez-Nevot et al., , 1989 Redondo et al., 1991; . However, few studies have analysed the mechanisms responsible for such alterations. In previous papers, we investigated changes in the expression of HLA class I antigens during malignant transformation of the laryngeal epithelium and some mechanisms involved , and we found several clinical and pathological correlations between HLA-ABC losses and aggressiveness (Esteban et al., 1990a) . MHC class II antigens were only found in verrucous cell carcinomas, thus DR expression seems to be associated with tumours with excellent prognosis (Esteban et al., 1990b (Wahi, 1972) , and all were scored according to Glanz's (Glanz, 1984) 
Survival analysis
The survival analysis calculated from 60 patients showed a high probability of tumour-related death for the T, N and score according to Glanz's classifications (Table II) . No discriminating effect on tumour-related death, however, could be detected on the expressional status of HLA-A, B or C/fJ2m antigens. In addition, the cell composition in the infiltrates did not affect the frequency of metastasis and the 5 year survival.
Discussion
In addition to genetic alterations, some events are probably needed to acquire the malignant phenotype of a tumour. Thus, cellular malignant transformation is frequently associated with alteration in MHC antigens (Garrido et al., 1993) , and these alterations may profoundly affect the way in which the tumour behaves, decreasing or enhancing specific anti-tumoral immune mechanisms (Festenstein, 1987 4.814 (7) 0.0982 aMeans of counting ten microscopic high-power fields. 1803 1988). Clinical studies on the MHC expressional status of malignant tumours and survival are very scarce (Moller et al., 1991; Passlick et al., 1994) . In our study, we showed that total loss of HLA-A, -B and -C antigens in laryngeal carcinomas is not a prognostic factor. However, series including a greater number of patients may improve the level of statistical significance, as univariate analysis has shown a strong relationship between HLA class I total loss and tumour aggressiveness (Esteban et al., 1990b) .
On the other hand, we have not found any significant difference between class I expression and the immunophenotype of infiltrating cells, and also between these TILs and survival. The exact role that lymphocytes may play against laryngeal cancer is unknown. There are few papers investigating the role of TILs in head and neck cancer, and results are inconclusive (Hiratsuka et al., 1984; Rabin et al., 1984; Harabuchi et al., 1985; Wolf et al., 1986; Boheim et al., 1987; Zeromski et al., 1986; Guo et al., 1987) . In breast and colon tumours, two reports performed multivariate analysis and they found that the amount of lymphocytic infiltrate was independently predictive of the risk of death (Marques et al., 1990; Kubota et al., 1992) , although they did not measure the immunophenotype of this infiltrate. Others have shown T cells to be a favourable prognostic sign, whereas B cells are generally not predominant in various human cancers (Shimokawara et al., 1982) . In contrast, some reports show evidence that tumours are stimulated into growth by host cells in the tumour stroma (Stewart and Tsai, 1993) . In this context, in vitro studies demonstrated that tumour-infiltrating leucocytes display an immune inhibitory effect (Fulton, 1987; Vose and Bonnard, 1982) . Other authors report important functional deficiencies in T cells (Gorski et al., 1994; Fu et al., 1989) .
Concerning Langerhans cells, a high density of these cells has been considered of favourable prognosis for patients with squamous cell carcinoma of the larynx in the univariate analysis (Gallo et al., 1991) . However, we found a very small proportion of Langerhans cells in our cases with no influence on prognosis.
The prospective study presented here confirms the paramount prognostic implication of T, N and Glanz's score on the relative risk of tumour-related death in our group of patients. It is important to stress these aspects in view of the reliability of our statements on MHC antigen expression and prognosis.
Although our survival results are very conclusive, we are reluctant to accept the idea that there is a null response of immune mechanisms. We cannot rule out different HLA class I expression in residual tumour cells after putatively curative resection, since a small proportion of cells with different expression are frequently present in human tumours (Cordon-Cardo et al., 1991) . On the other hand, the increased susceptibility of HLA class I-negative tumours to lysis by NK cells may influence metastatic potential and survival (Karre et al., 1986) , and finally, selective losses of HLA class I allelic products on tumours with positive expression for HLA-A, -B and -C antigens may frequently be present and also influence the metastatic potential (Honma et al., 1994) . Our group is currently investigating HLA phenotype in invasive breast carcinomas using anti-HLA polymorphic antibodies, and more than 88.5% of the tumours showed an altered HLA tumour phenotype, when compared with the peripheral blood lymphocytes of each patient (Cabrera et al., 1996) . In that paper, HLA-ABC total losses were found in a similar proportion to those in laryngeal carcinomas; however, it seems that those laryngeal tumours presenting 'normal' expression of HLA class I antigens could have allelic losses not shown with the MAbs used in our 1990 study, as demonstrated in breast cancer. Thus, alterations in HLA class I expression could be so common that statistical analysis may not detect the importance of HLA expression in tumour cells.
In conclusion, total loss of HLA-A, -B and -C expression is not associated with a high risk of tumour-related death. Further investigations with HLA allelic typing and other immunological markers are needed to evaluate prognosis in laryngeal carcinomas.
